Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Bailey

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Ophthalmology|November 19, 2015
First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular DegenerationJames S Talks, Andrew J Lotery, Faruque Ghanchi, et al.
Translational Vision Science & Technology|February 10, 2017
Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated SoftwareAlex S Willoughby, Stephanie J Chiu, Rachel K Silverman, et al.
Eye (London, England)|May 20, 2026
Pharmacological principles of intravitreal drug therapy and their implications for clinical practice: a primer for the ophthalmologistSamia Ezzine, Richard Gale, Clare Bailey, et al.
Ophthalmology and Therapy|January 10, 2024
XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular DegenerationJean-François Korobelnik, Varun Chaudhary, Paul Mitchell, et al.
Retina (Philadelphia, Pa.)|March 4, 2017
CLINICAL EVIDENCE OF THE MULTIFACTORIAL NATURE OF DIABETIC MACULAR EDEMAUsha Chakravarthy, Yit Yang, Andrew Lotery, et al.
Eye (London, England)|January 30, 2026
SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degenerationClare Bailey, Clemens Lange, Varun Chaudhary, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 18, 2020
Providing a Safe and Effective Intravitreal Treatment Service: Strategies for Service DeliveryWinfried Amoaku, Clare Bailey, Louise Downey, et al.
Eye (London, England)|March 22, 2022
The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practiceIan Pearce, Winfried Amoaku, Clare Bailey, et al.
Eye (London, England)|March 11, 2021
Epidemiology of moderately severe and severe non-proliferative diabetic retinopathy in South West EnglandClareece R Nevill, Irene M Stratton, Sonia S Maruti, et al.
Acta Ophthalmologica|June 28, 2021
Prevalence and incidence of diabetic retinopathy (DR) in the UK population of GloucestershirePeter H Scanlon, Clareece R Nevill, Irene M Stratton, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Ophthalmology|November 19, 2015
First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular DegenerationJames S Talks, Andrew J Lotery, Faruque Ghanchi, et al.
Translational Vision Science & Technology|February 10, 2017
Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated SoftwareAlex S Willoughby, Stephanie J Chiu, Rachel K Silverman, et al.
Eye (London, England)|May 20, 2026
Pharmacological principles of intravitreal drug therapy and their implications for clinical practice: a primer for the ophthalmologistSamia Ezzine, Richard Gale, Clare Bailey, et al.
Ophthalmology and Therapy|January 10, 2024
XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular DegenerationJean-François Korobelnik, Varun Chaudhary, Paul Mitchell, et al.
Retina (Philadelphia, Pa.)|March 4, 2017
CLINICAL EVIDENCE OF THE MULTIFACTORIAL NATURE OF DIABETIC MACULAR EDEMAUsha Chakravarthy, Yit Yang, Andrew Lotery, et al.
Eye (London, England)|January 30, 2026
SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degenerationClare Bailey, Clemens Lange, Varun Chaudhary, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 18, 2020
Providing a Safe and Effective Intravitreal Treatment Service: Strategies for Service DeliveryWinfried Amoaku, Clare Bailey, Louise Downey, et al.
Eye (London, England)|March 22, 2022
The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practiceIan Pearce, Winfried Amoaku, Clare Bailey, et al.
Eye (London, England)|March 11, 2021
Epidemiology of moderately severe and severe non-proliferative diabetic retinopathy in South West EnglandClareece R Nevill, Irene M Stratton, Sonia S Maruti, et al.
Acta Ophthalmologica|June 28, 2021
Prevalence and incidence of diabetic retinopathy (DR) in the UK population of GloucestershirePeter H Scanlon, Clareece R Nevill, Irene M Stratton, et al.
Pageof 10